- Recruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
This study looks at the possible link between a type 2 diabetes medicine called exenatide and pancreatic cancer. Researchers are comparing patients who started exenatide with those who started other diabetes medicines, using health records from several European countries.
For: Pancreatic CancerDenmark · Finland · France - AuthorisedTherapeutic exploratory (Phase II)
Visualizing beta cells in patients with a history of gestational diabetes.
This study looks at how a special scan can help us understand cells in the pancreas of women who have had diabetes during pregnancy. It aims to see if a new way of scanning can show how these cells are working and if it links to how well their bodies manage sugar.
For: Gestational diabetesNetherlands